From April 2023 Medicare has increased access to continuous glucose monitoring (CGM) in the US to people on insulin therapies who are also having hypoglycemia.
Medtronic plans to integrate its new insulin dosing algorithm, which is used in the 780G pump, with EOFlow’s pump and is offering to buy all
While continuous glucose monitors (CGMs) can provide real-time data and alerts to help people with diabetes make informed decisions about their health, it has been
A JDRF-funded research project has turned human pancreatic ductal cells into insulin-producing cells, offering promise for restoring the ability to make insulin in people living
A study supported by JDRF has found that hybrid closed-loop technology improves maternal glucose levels during pregnancy complicated by Type 1 diabetes, compared to traditional
It is estimated that around 35% of patients with Type 1 and Type 2 diabetes have elevated distress levels, but a digital health application (DiGA)
Abbott has announced new data from a real-world evidence study in Sweden showing that the use of the FreeStyle Libre continuous glucose monitoring system (CGM)
With the NICE appraisal of who in England and Wales should have access to hybrid closed-loop technology set to conclude by the end of the
Glooko has launched a sleek new Glooko Mobile App in order to make it easier for users with diabetes to navigate, to organize their data
Eli Lilly and Co has announced that it will buy privately held Versanis for potentially up to $1.93bn to strengthen its position in the fast-growing
